These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29781810)

  • 1. Active suppression rather than ignorance: tolerance to abacavir-induced HLA-B*57:01 peptide repertoire alteration.
    Phillips EJ; Mallal SA
    J Clin Invest; 2018 Jul; 128(7):2746-2749. PubMed ID: 29781810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.
    Norcross MA; Luo S; Lu L; Boyne MT; Gomarteli M; Rennels AD; Woodcock J; Margulies DH; McMurtrey C; Vernon S; Hildebrand WH; Buchli R
    AIDS; 2012 Jul; 26(11):F21-9. PubMed ID: 22617051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
    Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
    J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice.
    Song B; Aoki S; Liu C; Susukida T; Kuwahara S; Ito K
    Toxicology; 2021 Nov; 463():152971. PubMed ID: 34606953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
    Illing PT; Vivian JP; Dudek NL; Kostenko L; Chen Z; Bharadwaj M; Miles JJ; Kjer-Nielsen L; Gras S; Williamson NA; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
    Nature; 2012 Jun; 486(7404):554-8. PubMed ID: 22722860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation.
    Thomson PJ; Illing PT; Farrell J; Alhaidari M; Bell CC; Berry N; O'Neill PM; Purcell AW; Park KB; Naisbitt DJ
    Allergy; 2020 Mar; 75(3):636-647. PubMed ID: 31549414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Conformational Dynamics in Abacavir-Induced Hypersensitivity Syndrome.
    Fodor J; Riley BT; Kass I; Buckle AM; Borg NA
    Sci Rep; 2019 Jul; 9(1):10523. PubMed ID: 31324847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of Abacavir-Induced Remodelling of the Major Histocompatibility Complex Class I Peptide Repertoire.
    Illing PT; van Hateren A; Darley R; Croft NP; Mifsud NA; King S; Kostenko L; Bharadwaj M; McCluskey J; Elliott T; Purcell AW
    Front Immunol; 2021; 12():672737. PubMed ID: 34093574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.
    Metushi IG; Wriston A; Banerjee P; Gohlke BO; English AM; Lucas A; Moore C; Sidney J; Buus S; Ostrov DA; Mallal S; Phillips E; Shabanowitz J; Hunt DF; Preissner R; Peters B
    PLoS One; 2015; 10(5):e0124878. PubMed ID: 26024233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.
    Guo Y; Shi L; Hong H; Su Z; Fuscoe J; Ning B
    Sci China Life Sci; 2013 Feb; 56(2):119-24. PubMed ID: 23393027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
    Song B; Aoki S; Liu C; Susukida T; Ito K
    Toxicol Sci; 2018 Apr; 162(2):713-723. PubMed ID: 29319822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant.
    Martin AM; Nolan D; Gaudieri S; Almeida CA; Nolan R; James I; Carvalho F; Phillips E; Christiansen FT; Purcell AW; McCluskey J; Mallal S
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4180-5. PubMed ID: 15024131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Elements Recognized by Abacavir-Induced T Cells.
    Yerly D; Pompeu YA; Schutte RJ; Eriksson KK; Strhyn A; Bracey AW; Buus S; Ostrov DA
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28686208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B*5701 screening for hypersensitivity to abacavir.
    Mallal S; Phillips E; Carosi G; Molina JM; Workman C; Tomazic J; Jägel-Guedes E; Rugina S; Kozyrev O; Cid JF; Hay P; Nolan D; Hughes S; Hughes A; Ryan S; Fitch N; Thorborn D; Benbow A;
    N Engl J Med; 2008 Feb; 358(6):568-79. PubMed ID: 18256392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses.
    Adam J; Wuillemin N; Watkins S; Jamin H; Eriksson KK; Villiger P; Fontana S; Pichler WJ; Yerly D
    PLoS One; 2014; 9(4):e95339. PubMed ID: 24751900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review.
    Cargnin S; Jommi C; Canonico PL; Genazzani AA; Terrazzino S
    Pharmacogenomics; 2014 May; 15(7):963-76. PubMed ID: 24956250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity.
    Manglani MV; Gabhale YR; Lala MM; Sekhar R; More D
    Indian Pediatr; 2018 Feb; 55(2):140-141. PubMed ID: 29242412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Abacavir-Induced Structural Alterations in Human Leukocyte Antigen-B*57 : 01 Using Phage Display.
    Shirayanagi T; Aoki S; Fujimori S; Watanabe K; Aida T; Hirasawa M; Kumagai K; Hoshino T; Ito K
    Biol Pharm Bull; 2020; 43(6):1007-1015. PubMed ID: 32475910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HLA-B*5701 and abacavir hypersensitivity reaction].
    Servonnet A; Leclercq E; Delacour H; Ceppa F
    Pathol Biol (Paris); 2010 Dec; 58(6):e95-100. PubMed ID: 19243901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.
    Ostrov DA; Grant BJ; Pompeu YA; Sidney J; Harndahl M; Southwood S; Oseroff C; Lu S; Jakoncic J; de Oliveira CA; Yang L; Mei H; Shi L; Shabanowitz J; English AM; Wriston A; Lucas A; Phillips E; Mallal S; Grey HM; Sette A; Hunt DF; Buus S; Peters B
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9959-64. PubMed ID: 22645359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.